Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription 20.01.2025 1 Am J Cardiol 1 Am J Clin Nutr 1 BMC Ophthalmol 3 Diabet Med 2 Diabetes 3 Diabetes Care 9 Diabetes Obes Metab 4 Diabetologia 1 J Autoimmun 5 J Clin Endocrinol Metab 3 J Diabetes Complications 1 J Nutr 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. NUSCA A, Di Bitonto MP, Spano A, Federico B, et al
   Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention.
   Am J Cardiol. 2025 Jan 11:S0002-9149(25)00015.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. LIU B, Hu Y, Wang S, Wang M, et al
   Lignan Intake and Mortality Among Adults with Incident Type 2 Diabetes-Prospective Cohort Studies.
   Am J Clin Nutr. 2025 Jan 9:S0002-9165(25)00008.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

3. SMITH JD, Sapoznik KA, Bisignano K, Benoit J, et al
   Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study.
   BMC Ophthalmol. 2025;25:24.
   PubMed         Abstract available
   
   

   
   Diabet Med

4. CAPTIEUX M, Guthrie B, Lawton J
   Does remission of type 2 diabetes matter? A qualitative study of healthcare professionals' perspectives and views about supporting remission in primary care.
   Diabet Med. 2025 Jan 18:e15515. doi: 10.1111/dme.15515.
   PubMed         Abstract available
   
   
5. VENKATESH KK, Grobman WA, Wu J, Shah NS, et al
   Hypertensive disorders of pregnancy and gestational diabetes mellitus and predicted risk of maternal cardiovascular disease 10-14 years after delivery: A prospective cohort.
   Diabet Med. 2025 Jan 17:e15516. doi: 10.1111/dme.15516.
   PubMed         Abstract available
   
   
6. BUECHNER H, Unadkat S, Skeldon J, Jones GC, et al
   A trauma-informed approach to type 1 diabetes mellitus in adults.
   Diabet Med. 2025 Jan 13:e15510. doi: 10.1111/dme.15510.
   PubMed         Abstract available
   
   

   
   Diabetes

7. JIA X, Wenzlau JM, Zhang C, Dong F, et al
   Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
   Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571.
   PubMed         Abstract available
   
   
8. WEI J, Yu Y, Wu H, Li Y, et al
   Clonal haematopoiesis of indeterminate potential and risk of microvascular complications among individuals with type 2 diabetes: a cohort study.
   Diabetes. 2025 Jan 13:db240841. doi: 10.2337/db24-0841.
   PubMed         Abstract available
   
   

   
   Diabetes Care

9. MYNAREK IM, Krogvold L, Mork FB, Lawaetz TWH, et al
   Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial.
   Diabetes Care. 2025 Jan 13:dc242121. doi: 10.2337/dc24-2121.
   PubMed         Abstract available
   
   
10. KOME AM, Chandran MM, Tungate Lopez SS, Buse JB, et al
    One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.
    Diabetes Care. 2025 Jan 14:dc242575. doi: 10.2337/dc24-2575.
    PubMed        
    
    
11. EGEDE LE, Campbell JA, Linde S, Walker RJ, et al
    Financial Incentives, Income Supplementation, Cash Transfer, and Universal Basic Income Interventions in Diabetes: Understanding Differences and Effectiveness: A Scoping Review.
    Diabetes Care. 2025 Jan 14:dci240072. doi: 10.2337/dci24-0072.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

12. WU X, Huang Q, Ding Y, Cao Q, et al
    Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial.
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16180.
    PubMed         Abstract available
    
    
13. SUZUKI R, Shoji S, Yoshinaga Y, Kosakai Y, et al
    Risk of insulin initiation with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A real-world claims database study in Japan.
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16188.
    PubMed         Abstract available
    
    
14. MATSUBAYASHI Y, Fujihara K, Khin L, Ferreira ED, et al
    Association of changes in the type 2 diabetes and MASLD/related SLD status with risk of developing cardiovascular disease.
    Diabetes Obes Metab. 2025 Jan 15. doi: 10.1111/dom.16196.
    PubMed         Abstract available
    
    
15. SUN M, Liu Q, Liu Y, Ning N, et al
    Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study.
    Diabetes Obes Metab. 2025 Jan 15. doi: 10.1111/dom.16184.
    PubMed         Abstract available
    
    
16. LEITE NC, Villela-Nogueira CA, Santos LV, Cardoso CRL, et al
    Prognostic value of changes in vibration-controlled transient elastography parameters for liver, cardiovascular and mortality outcomes in individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: The Rio de Janeiro
    Diabetes Obes Metab. 2025 Jan 16. doi: 10.1111/dom.16195.
    PubMed         Abstract available
    
    
17. LIN CM, Chen JC, Meyerowitz-Katz G, Huang YN, et al
    Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study.
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16191.
    PubMed         Abstract available
    
    
18. LU W, Xie L, Zhang Y, Gao H, et al
    Long-term blood glucose control via glucose-activated transcriptional regulation of insulin analogue in type 1 diabetes mice.
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16197.
    PubMed         Abstract available
    
    
19. WANG Y, Lin T, Lu J, He W, et al
    Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study.
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16183.
    PubMed         Abstract available
    
    
20. 
    Correction to "Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study".
    Diabetes Obes Metab. 2025 Jan 13. doi: 10.1111/dom.16204.
    PubMed        
    
    

    
    Diabetologia

21. LIN YK, Ye W, Hepworth E, Agni A, et al
    Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
    Diabetologia. 2025;68:433-443.
    PubMed         Abstract available
    
    
22. CHEN Z, Qian F, Liu B, Zong G, et al
    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
    Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
    PubMed         Abstract available
    
    
23. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
    PubMed         Abstract available
    
    
24. MENDOZA K, Barquera S, Tobias DK
    Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
    Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
    PubMed         Abstract available
    
    

    
    J Autoimmun

25. AROWOSEGBE A, Guo Z, Vanderleeden E, Derr AG, et al
    Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats.
    J Autoimmun. 2025;151:103358.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

26. WANG S, Zhang Y, Balati A, Li B, et al
    Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
    PubMed         Abstract available
    
    
27. GERA S, Rearson A, Baker G, Douvas JL, et al
    Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
    PubMed         Abstract available
    
    
28. AN J, Zhang S, Cheng X, Jia C, et al
    The Association between Serum Polychlorinated Biphenyls and Incident Cardiovascular Disease among Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf014. doi: 10.1210.
    PubMed         Abstract available
    
    
29. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
    Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
    PubMed         Abstract available
    
    
30. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
    Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

31. SCHMITTLING KA
    Behavioral health comorbidities in hospital outcomes post-lower extremity amputation in patients with type 1 and type 2 diabetes.
    J Diabetes Complications. 2025;39:108949.
    PubMed         Abstract available
    
    
32. HE Y, Ye M, Shen Z, Zhong Z, et al
    Correlation between lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: A cross-sectional study.
    J Diabetes Complications. 2025;39:108950.
    PubMed         Abstract available
    
    
33. LIU S, Ke J, Feng X, Xu Y, et al
    Diabetic microvascular complications are associated with left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2024;39:108947.
    PubMed         Abstract available
    
    

    
    J Nutr

34. WANG J, Zhang X, Zhan S, Han F, et al
    Possible Metabolic Remodeling based on de novo Biosynthesis of L-serine in Se-Subtoxic or -Deficient Mammals.
    J Nutr. 2025;155:9-26.
    PubMed         Abstract available
    
    

    
    PLoS One

35. TING KH, Yang PJ, Huang JY, Lee CY, et al
    The severity of coronary heart disease and the incidence of later diabetic retinopathy in diabetic population: A retrospective cohort study.
    PLoS One. 2025;20:e0316112.
    PubMed         Abstract available
    
    
36. KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
    Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
    PLoS One. 2025;20:e0313051.
    PubMed         Abstract available
    
    
37. CHAUDHRY UAR, Fortescue R, Bowen L, Woolford SJ, et al
    Comparison of mortality in people with type 2 diabetes between different ethnic groups: Systematic review and meta-analysis of longitudinal studies.
    PLoS One. 2025;20:e0314318.
    PubMed         Abstract available
    
    
38. NAGY AM, Fahmy HA, Abdel-Hameed MF, Taher RF, et al
    Protective effects of Euphorbia heterophylla against testicular degeneration in streptozotocin-induced diabetic rats in relation to phytochemical profile.
    PLoS One. 2025;20:e0314781.
    PubMed         Abstract available
    
    
39. DAEI S, Hosseini-Esfahani F, Ildarabadi A, Mirmiran P, et al
    Associations between the Global Diet Quality Score and risk of type 2 diabetes: Tehran lipid and glucose study.
    PLoS One. 2025;20:e0313886.
    PubMed         Abstract available
    
    
40. ANOSOVA O, Head A, Collins B, Alexiou A, et al
    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.
    PLoS One. 2025;20:e0313877.
    PubMed         Abstract available
    
    
41. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    The impact of tuberculosis-induced hyperglycemia on pulmonary microbiota and airway mucus secretion in individuals not previously diabetic: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0316810.
    PubMed         Abstract available
    
    
42. ZHOU J, Yang X
    Association between depression and the prevalence and prognosis of prediabetes: Data from National Health and Nutrition Examination Survey (NHANES) 2013-2018.
    PLoS One. 2025;20:e0304303.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.